HHLR ADVISORS, LTD.
Institutional investor · Portfolio as of Q2 2024
Top Holdings78 positions
Pinduoduo Inc | 8.9M | $1.2B | 29.2% | $96.79 | +37.35% | 9 qtrssince 2022-Q2 | Decreased 0 |
BEIGENE LTD | 5.2M | $738.6M | 18.2% | $136.90 | +4.22% | 23 qtrssince 2018-Q4 | Unchanged 0 |
Alibaba Group Holding Ltd | 5.4M | $387.3M | 9.6% | $70.86 | -1.00% | 9 qtrssince 2022-Q2 | Increased 98 |
KE HLDGS INC | 23.2M | $327.9M | 8.1% | $21.08 | -35.45% | 16 qtrssince 2020-Q3 | Decreased 0 |
LEGEND BIOTECH CORP | 6.6M | $293.9M | 7.3% | $50.33 | -12.00% | 17 qtrssince 2020-Q2 | Increased 67 |
Vipshop Holdings Ltd | 14.8M | $192.8M | 4.8% | $12.04 | +0.01% | 14 qtrssince 2021-Q1 | Increased 90 |
NetEase Inc | 1.4M | $132.5M | 3.3% | $87.78 | +2.95% | 7 qtrssince 2022-Q4 | Increased 89 |
ARRIVENT BIOPHARMA INC | 4.5M | $83.2M | 2.1% | $17.95 | +3.37% | 2 qtrssince 2024-Q1 | Increased 58 |
Ctrip.com International Ltd | 1.4M | $65.1M | 1.6% | $46.77 | 0.00% | 1 qtr | New 67 |
KINIKSA PHARMACEUTICALS INTL | 3.1M | $58.7M | 1.4% | $18.67 | 0.00% | 1 qtr | New 67 |
Futu Holdings Ltd | 716,089 | $47M | 1.2% | $63.08 | 0.00% | 1 qtr | New 67 |
ENFUSION INC | 5M | $42.4M | 1.0% | — | — | 11 qtrssince 2021-Q4 | Unchanged 0 |
CYTEK BIOSCIENCES INC | 6.7M | $37.1M | 0.9% | $21.41 | -73.94% | 12 qtrssince 2021-Q3 | Unchanged 0 |
BRIDGEBIO PHARMA INC | 1.4M | $35.2M | 0.9% | $28.21 | -10.20% | 21 qtrssince 2019-Q2 | Increased 41 |
Danaher Corp | 108,700 | $27.2M | 0.7% | $225.13 | +10.05% | 5 qtrssince 2023-Q2 | Decreased 0 |
DoorDash Inc | 247,912 | $27M | 0.7% | $116.24 | +69.05% | 15 qtrssince 2020-Q4 | Decreased 0 |
salesforce.com Inc | 96,358 | $24.8M | 0.6% | $206.97 | +10.71% | 18 qtrssince 2020-Q1 | Decreased 0 |
Facebook Inc | 44,476 | $22.4M | 0.6% | $499.18 | +0.51% | 2 qtrssince 2024-Q1 | Increased 65 |
AstraZeneca PLC | 271,749 | $21.2M | 0.5% | $151.98 | +4.75% | 1 qtr | New 56 |
China Lodging Group Ltd | 568,613 | $18.9M | 0.5% | $42.46 | -27.23% | 17 qtrssince 2020-Q2 | Decreased 0 |
HHLR ADVISORS, LTD. manages $4.1B across 78 positions as of Q2 2024. Top holdings: PDD (29.2%), ONC (18.2%), BABA (9.6%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2.5/5.0.
Active quarter - 25 new positions, 10 exits, 17 increased. Top move: BABA (INCREASED, conviction 98). Portfolio: $4.1B across 78 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR